A treatment option for adults with relapsed or refractory multiple myeloma who have received at least four treatment regimens, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody to treat their multilple myeloma, and their cancer has come back or did not respond to prior treatment. TECVAYLI^TM is approved based on patient response. Data are not yet available to show if TECVAYLI^TM improves survival or symptoms.

It is not known if TECVAYLI^TM is safe and effective in children.

Download this brochure to review the Medication Guide and additional information about getting started with TECVAYLI™.

Get the Guide

There are support and resource options for TECVAYLI™ .

Explore Now

Sign up for the latest information about TECVAYLI^™

Janssen Biotech, Inc., our affiliates, and our service providers will use the information that you provide to send you personalized communications about TECVAYLI^™ and relapsed or refractory multiple myeloma and your optional requests, and to research, develop, and improve our products and services. Please note that the subject line of email messages that you receive may include TECVAYLI^™ or relapsed or refractory multiple myeloma. You may unsubscribe from these communications by following the instructions in them. Our Privacy Policy further governs the use of the information you provide.

By providing consent, you agree to the collection and use of your Sensitive Personal Information (SPI). Examples of SPI may include, but are not limited, to health-related information. We use this information consistent with our Privacy Policy, including to personalize the information you receive, fulfill any requests you submit, and to research, develop, and improve our products and services. By checking the box, you indicate that you read, understand, and agree to such collection and use of your SPI.

This field is required.

*REQUIRED FIELD

First Name*

First Name is required.

Last Name*

Last Name is required.

Email Address*

Valid Email is required.

ZIP Code*

Valid ZIP Code is required.

I am a...*

Patient

Caregiver

Please select if you are a Patient or Caregiver.

Select your communication preference:*

I would like to receive information and updates about other products and services from Janssen Biotech, Inc.

Do not fill out this field

Download this brochure to review the Medication Guide and additional information about getting started with TECVAYLI™.

Sign up for the latest information about TECVAYLI™

Sign up for the latest information about TECVAYLI^™